Clinical trial
Ropinirole in the Treatment of Bipolar Depression
NCT00314821 · Cambridge Health Alliance, Other · Completed
Key facts
| NCT number | NCT00314821 |
|---|---|
| Title | Ropinirole in the Treatment of Bipolar Depression |
| Official title | A Randomized, Double-blind, Placebo-controlled Study of the Efficacy of Ropinirole in the Treatment of Depression in Bipolar Disorder |
| Lead sponsor | Cambridge Health Alliance, Other |
| Collaborators | Emory University GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | ropinirole |
| Enrollment | 40 |
| Start date | Sep 1, 2005 |
| Primary completion | Jun 1, 2007 |
| Completion | Mar 17, 2008 |
| First posted | Apr 17, 2006 |
| Last update posted | Apr 18, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: